Predominant short stature diagnoses were GH deficiency (63%), idiopathic short stature (13%), and Turner syndrome (8%), with a mean SD follow-up of 4.2 3.2 years (92,000 person-years [PY])
GHK-Cu gene activation is building momentum
In vivo models treated with this peptide showed a dramatic reduction in both mechanical and thermal hypersensitivity, opening a promising new therapeutic avenue for targeted pain relief
Large-scale human studies and meta-analyses have largely been reassuring, showing no clear evidence of a significant increase in MTC risk for the general population
Greater receptor binding: Semaglutide binds more effectively to GLP-1 receptors, producing stronger signaling
This distinction highlights why each compound occupies a separate niche within peptide researchone centered on hormonal optimization, the other on systemic metabolic intervention